Scholarlink

Background <p>Marine-derived fungi are prolific producers of structurally diverse secondary metabolites with significant pharmaceutical potential. The discovery of natural products has been unprecedentedly accelerated by the prediction of biosynthetic gene clusters (BGCs) within the whole-genome context. This study presents the whole-genome sequencing, comprehensive annotation, and biosynthetic potential predictions of the sponge-associated fungus <i>Aspergillus puulaauensis</i> Hmp-F48.</p> Results <p>Genome sequencing of <i>A. puulaauensis</i> Hmp-F48 generated a high-quality draft assembly of 35.86&#xa0;Mb. Structural annotation revealed a complex genomic architecture, comprising 10,611 protein-coding genes, 210 non-coding RNAs, and 155 tRNAs. Functional annotation using NR, Swiss-Prot, GO, KEGG, and eggNOG databases highlighted significant enrichment in biosynthetic, metabolic, and transport processes. AntiSMASH analysis identified 78 putative BGCs, including 16 type I polyketide synthase (T1PKS), 27 nonribosomal peptide synthetase (NRPS), 7 hybrid PKS-NRPS, 9 terpene-related clusters, 6 RiPP-related clusters and 13 clusters associated with other secondary metabolites. Several clusters exhibited high homology to known BGCs responsible for bioactive secondary metabolites, including asperthecin, sterigmatocystin, calbistrins, F-9775&#xa0;A/B, nidulanin A, aspercryptins, fellutamide B, acetylaranotin, burnettramic acid A, equisetin, and pyranonigrin E. Experimental isolation confirmed the presence of PKS-derived metabolites, including sterigmatocystin, averantin, and decumbenones — one of which represents a previously undescribed congener.</p> Conclusions <p>This study highlights the extensive biosynthetic potential of <i>A. puulaauensis</i> Hmp-F48, offering valuable insights into its capacity for secondary metabolite production.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Genomic insights into the biosynthetic capacity of the sponge-associated fungus Aspergillus puulaauensis Hmp-F48

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月26日

查看全文
  • Yue Yan,
  • Xiao Wang,
  • Qiang Ma,
  • Yijie Lou,
  • Zhe Chen,
  • Ning Li,
  • Nan Wang

摘要

Background

Marine-derived fungi are prolific producers of structurally diverse secondary metabolites with significant pharmaceutical potential. The discovery of natural products has been unprecedentedly accelerated by the prediction of biosynthetic gene clusters (BGCs) within the whole-genome context. This study presents the whole-genome sequencing, comprehensive annotation, and biosynthetic potential predictions of the sponge-associated fungus Aspergillus puulaauensis Hmp-F48.

Results

Genome sequencing of A. puulaauensis Hmp-F48 generated a high-quality draft assembly of 35.86 Mb. Structural annotation revealed a complex genomic architecture, comprising 10,611 protein-coding genes, 210 non-coding RNAs, and 155 tRNAs. Functional annotation using NR, Swiss-Prot, GO, KEGG, and eggNOG databases highlighted significant enrichment in biosynthetic, metabolic, and transport processes. AntiSMASH analysis identified 78 putative BGCs, including 16 type I polyketide synthase (T1PKS), 27 nonribosomal peptide synthetase (NRPS), 7 hybrid PKS-NRPS, 9 terpene-related clusters, 6 RiPP-related clusters and 13 clusters associated with other secondary metabolites. Several clusters exhibited high homology to known BGCs responsible for bioactive secondary metabolites, including asperthecin, sterigmatocystin, calbistrins, F-9775 A/B, nidulanin A, aspercryptins, fellutamide B, acetylaranotin, burnettramic acid A, equisetin, and pyranonigrin E. Experimental isolation confirmed the presence of PKS-derived metabolites, including sterigmatocystin, averantin, and decumbenones — one of which represents a previously undescribed congener.

Conclusions

This study highlights the extensive biosynthetic potential of A. puulaauensis Hmp-F48, offering valuable insights into its capacity for secondary metabolite production.